Active Awards Portfolio Dashboard

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards

Disease Cell Typesort descending Therapeutic or Technology Institution Stage Project Objective Details
HIV/AIDS Personalized cell therapy COH
IND
Blood Cancer,
Bone Marrow Transplant and Viral Infection
Adult Stem Cell Donor cell therapy CHLA
Clinical Trial, Phase 1 or Phase 1/2
HIV/AIDS Adult Stem Cell Gene editing tools USC
Tool/Resources/Bottleneck
Intestinal Disease,
Neurological Disorders
Adult Stem Cell Specific Cell Type Derivation Stanford
Tool/Resources/Bottleneck
Prostate Cancer Adult Stem Cell Gene-modified, personalized cell therapy Poseida Therapeutics, Inc.
IND
Multiple Myeloma Adult Stem Cell Gene-modified, personalized cell therapy Poseida Therapeutics, Inc.
Clinical Trial, Phase 1 or Phase 1/2
Blood Disorders Adult Stem Cell Cell processing & handling UCSF
Tool/Resources/Bottleneck
Bone or Cartilage Disease Adult Stem Cell Donor cell therapy UCLA
Proof of Concept
Brain Cancer Adult Stem Cell Gene-modified, personalized cell therapy UCSF
Development Candidate, Proof of Concept
Age-related macular degeneration Adult Stem Cell Donor cell therapy Stanford
Pre-IND/IDE or Equivalent
Kidney Failure Adult Stem Cell Donor cell therapy Medeor Therapeutics
Clinical Trial, Phase 3
Ovarian Cancer Adult Stem Cell Gene-modified, personalized cell therapy COH
Development Candidate, Proof of Concept
Hemophilia A Adult Stem Cell Gene modification COH
Development Candidate, Proof of Concept
Autism Adult Stem Cell Gene-modified, donor cell therapy UC Davis
Development Candidate, Proof of Concept
Spina Bifida Adult Stem Cell Donor cell therapy UC Davis
IND
Skeletal/Smooth Muscle disorders Adult Stem Cell Protein/peptide therapy Stanford
Research Insights
Stroke Adult Stem Cell Gene-modified, donor cell therapy SanBio, Inc.
Clinical Trial, Phase 2
Blood Cancer Adult Stem Cell Donor cell therapy Angiocrine
Clinical Trial, Phase 1 or Phase 1/2
Sickle Cell Disease Adult Stem Cell Donor cell therapy COH
Clinical Trial, Phase 1 or Phase 1/2
Blood Disorders,
Blood Cancer
Adult Stem Cell Small molecule therapy UCLA
Development Candidate
Heart Disease,
Danon Disease
Adult Stem Cell Gene-modified, personalized cell therapy UCSD
Development Candidate, Proof of Concept
Alpha Thalassemia Major Adult Stem Cell Donor cell therapy UCSF
Clinical Trial, Phase 1 or Phase 1/2
HIV/AIDS Adult Stem Cell Gene-modified, personalized cell therapy CIT
Proof of Concept
Severe Combined Immunodeficiency, Artemis deficient (ART-SCID) Adult Stem Cell Gene-modified, personalized cell therapy UCSF
Clinical Trial, Phase 1 or Phase 1/2
Cancer Adult Stem Cell Gene-modified, donor cell therapy UCLA
Development Candidate, Proof of Concept
HIV/AIDS Adult Stem Cell Gene-modified, personalized cell therapy COH
Clinical Trial, Phase 1 or Phase 1/2
Other Adult Stem Cell Cell imaging & tracking Stanford
Tool/Resources/Bottleneck
Diabetic Wounds,
Skin Disease
Adult Stem Cell Donor cell therapy UC Davis
Pre-IND/IDE or Equivalent
Cystinosis Adult Stem Cell Gene-modified, personalized cell therapy UCSD
IND
Kidney Failure Adult Stem Cell Donor cell therapy Stanford
Clinical Trial, Phase 1 or Phase 1/2
B cell cancers,
Leukemia
Adult Stem Cell Gene-modified, personalized cell therapy Stanford
Clinical Trial, Phase 1 or Phase 1/2
Cystic Fibrosis Adult Stem Cell Gene-modified, personalized cell therapy Stanford
Development Candidate
Immune Disease,
Severe Combined Immunodeficiency, X-linked (X-SCID)
Adult Stem Cell Antibody Stanford
Clinical Trial, Phase 1 or Phase 1/2
Amyotrophic Lateral Sclerosis Adult Stem Cell Gene-modified, personalized cell therapy BrainStorm
Clinical Trial, Phase 3
Vascular Disease Adult Stem Cell Personalized cell therapy UC Davis
Proof of Concept
Skeletal/Smooth Muscle disorders Adult Stem Cell Small molecule therapy Stanford
Development Candidate
Heart disease associated with Duchenne muscular dystrophy Adult Stem Cell Donor cell therapy Capricor
Clinical Trial, Phase 2
Beta Thalassemia Adult Stem Cell Gene-modified, personalized cell therapy Sangamo
Clinical Trial, Phase 1 or Phase 1/2
Melanoma,
Skin cancer
Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Clinical Trial, Phase 1 or Phase 1/2
Blood Cancer Adult Stem Cell Gene-modified, donor cell therapy Angiocrine
Clinical Trial, Phase 1 or Phase 1/2
HIV-related Lymphoma,
HIV/AIDS
Adult Stem Cell Gene-modified, personalized cell therapy UC Davis
Clinical Trial, Phase 1 or Phase 1/2
Kidney Failure Adult Stem Cell Biologic Humacyte
Clinical Trial, Phase 3
Immune Disease,
Severe Combined Immunodeficiency, Adenosine deaminase-deficient (ADA-SCID)
Adult Stem Cell Gene-modified, personalized cell therapy Orchard Therapeutics
Clinical Trial, Phase 2
Corneal Damage Adult Stem Cell Personalized cell therapy UCLA
IND
Osteonecrosis Adult Stem Cell Small molecule therapy UC Davis
Clinical Trial, Phase 1 or Phase 1/2
Sickle Cell Disease Adult Stem Cell Gene-modified, personalized cell therapy Stanford
IND
Blood Disorders Adult Stem Cell Cell processing & handling Stanford
Research Insights
Immune Disease,
X-linked Chronic Granulomatous Disease
Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Clinical Trial, Phase 1 or Phase 1/2
Lung Cancer Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Clinical Trial, Phase 1 or Phase 1/2
Retinitis Pigmentosa Adult Stem Cell Donor cell therapy jCyte
Clinical Trial, Phase 2

Pages

Icon for csv export